Scarica l'app Stockscreener
8.86
2.31%
0.20
Precedente Chiudi:
$8.66
Aprire:
$8.71
Volume 24 ore:
64,160
Relative Volume:
0.53
Capitalizzazione di mercato:
$127.89M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-1.7475
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
+2.67%
1M Prestazione:
+1.96%
6M Prestazione:
-44.14%
1 anno Prestazione:
-65.21%
Intervallo 1D:
$8.68
$9.0367
Intervallo di 1 settimana:
$8.52
$9.0367
Portata 52W:
$7.8701
$25.83
Anika Therapeutics Inc Stock (ANIK) Company Profile
Nome
Anika Therapeutics Inc
Settore
Telefono
(781) 457-9000
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Confronta ANIK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.87 | 124.86M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
147.54 | 65.12B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.06 | 47.66B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.275 | 42.03B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.34 | 21.08B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
409.81 | 18.26B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | B. Riley Securities | Buy |
| 2024-11-01 | Reiterato | Barrington Research | Outperform |
| 2023-08-14 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Ripresa | Stephens | Equal-Weight |
| 2022-03-09 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Iniziato | Stephens | Overweight |
| 2021-07-16 | Iniziato | UBS | Neutral |
| 2020-12-16 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-01-10 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Iniziato | BWS Financial | Sell |
| 2019-09-24 | Reiterato | Barrington Research | Outperform |
| 2019-09-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Downgrade | Sidoti | Buy → Neutral |
| 2018-07-27 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Reiterato | Barrington Research | Outperform |
| 2016-05-09 | Aggiornamento | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Anika Therapeutics Inc Borsa (ANIK) Ultime notizie
Acadian Asset Management LLC Raises Stake in Anika Therapeutics Inc. $ANIK - MarketBeat
Sectors Review: Is Anika Therapeutics Inc. affected by consumer sentimentMarket Trend Report & Growth Focused Entry Point Reports - خودرو بانک
US Stocks Recap: Is ATHM in a bullish channelWeekly Earnings Recap & Risk Managed Trade Strategies - خودرو بانک
Trend Report: What analysts say about FreightCar America Inc stockMarket Growth Summary & Fast Entry Momentum Trade Alerts - خودرو بانک
Institution Moves: Will Anika Therapeutics Inc. benefit from AI trendsPortfolio Return Report & Consistent Return Strategy Ideas - خودرو بانک
Published on: 2025-09-17 06:32:25 - خودرو بانک
Bond Watch: Is Anika Therapeutics Inc. affected by consumer sentimentJuly 2025 Weekly Recap & Daily Stock Trend Reports - خودرو بانک
Aug Update: What is the PEG ratio of Anika Therapeutics IncJuly 2025 PostEarnings & Daily Profit Maximizing Trade Tips - خودرو بانک
Will Anika Therapeutics Inc. outperform the market in YEARPortfolio Value Report & Fast Moving Stock Watchlists - خودرو بانک
Published on: 2025-09-17 00:53:30 - خودرو بانک
Earnings Miss: What is the target price for Anika Therapeutics Inc stock2025 Key Lessons & Verified Stock Trade Ideas - خودرو بانک
Aug Sentiment: Can Envoy Medical Inc. Equity Warrant benefit from deglobalizationInsider Buying & Low Volatility Stock Suggestions - خودرو بانک
Big Money Moves: Is Anika Therapeutics Inc gaining market shareOil Prices & Safe Entry Momentum Stock Tips - خودرو بانک
Aug Shorts: How do insiders feel about Anika Therapeutics Inc2025 Buyback Activity & Stepwise Trade Execution Plans - خودرو بانک
Detecting price anomalies in Anika Therapeutics Inc. with AIPrice Action & Reliable Volume Spike Trade Alerts - newser.com
Will Anika Therapeutics Inc. see short term momentumJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Predicting Anika Therapeutics Inc. trend using moving averagesJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Anika Therapeutics Inc. recovery potential after sell off2025 Macro Impact & Daily Volume Surge Signals - newser.com
Building trade automation scripts for Anika Therapeutics Inc.July 2025 Retail & Daily Chart Pattern Signals - newser.com
Full technical analysis of Anika Therapeutics Inc. stockJuly 2025 Closing Moves & Accurate Technical Buy Alerts - newser.com
What technical models suggest about Anika Therapeutics Inc.’s comebackWeekly Market Summary & Safe Entry Zone Identification - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
How to read the order book for Anika Therapeutics Inc.Share Buyback & Step-by-Step Trade Execution Guides - Newser
Real time breakdown of Anika Therapeutics Inc. stock performanceJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
What to expect from Anika Therapeutics Inc. in the next 30 daysGap Down & Fast Entry and Exit Trade Plans - Newser
Cove Street Capital LLC Acquires New Position in Anika Therapeutics Inc. $ANIK - MarketBeat
Aug Patterns: Is Anika Therapeutics Inc. gaining market shareDividend Hike & Accurate Trade Setup Notifications - Lancaster City Council
Nuveen LLC Acquires Shares of 41,315 Anika Therapeutics Inc. $ANIK - MarketBeat
Anika Therapeutics Inc. Price Targets Raised After ReboundJuly 2025 Gainers & High Conviction Buy Zone Picks - beatles.ru
Reversal Confirmed Anika Therapeutics Inc. Stock Rallies Above MAJuly 2025 Movers & Fast Momentum Stock Entry Tips - beatles.ru
Published on: 2025-09-08 20:31:28 - beatles.ru
Trendline Breach Raises Concern for Anika Therapeutics Inc. Investors2025 Market Overview & Entry Point Confirmation Signals - beatles.ru
What is the target price for Anika Therapeutics Inc. stock2025 Price Targets & Consistent Profit Alerts - beatles.ru
Should you buy the dip on Anika Therapeutics Inc.July 2025 Catalysts & Safe Entry Trade Reports - beatles.ru
Will Anika Therapeutics Inc. rebound enough to break even2025 Bull vs Bear & Smart Money Movement Alerts - Newser
Statistical indicators supporting Anika Therapeutics Inc.’s strengthInsider Buying & Expert-Curated Trade Recommendations - Newser
What data driven models say about Anika Therapeutics Inc.’s futureQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser
How cyclical is Anika Therapeutics Inc.’s revenue stream2025 Technical Overview & Consistent Profit Alerts - خودرو بانک
Does Anika Therapeutics Inc. have declining or rising EPSStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
Risk adjusted return profile for Anika Therapeutics Inc. analyzedJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Can Anika Therapeutics Inc. expand into new marketsPortfolio Performance Report & Fast Gain Stock Trading Tips - خودرو بانک
Visual analytics tools that track Anika Therapeutics Inc. performanceJobs Report & Smart Swing Trading Alerts - Newser
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Anika Therapeutics Announces Inducement Grants for New Hire Under Nasdaq Listing Rule 5635(c)(4) - AInvest
2,500 Shares at $9.15: Anika Therapeutics Awards Inducement Stock Options to New Non-Executive Hire - Stock Titan
Understanding Anika Therapeutics Inc.’s price movementJuly 2025 Highlights & Entry Point Confirmation Signals - Newser
Regression analysis insights on Anika Therapeutics Inc. performanceMarket Performance Report & Daily Entry Point Alerts - Newser
Price momentum metrics for Anika Therapeutics Inc. explainedPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Does Anika Therapeutics Inc. fit your quant trading modelJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Pomerantz LLP Investigates Potential Claims Involving Anika Therapeutics Investors - geneonline.com
Published on: 2025-09-04 09:02:32 - Newser
Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anika Therapeutics Inc Azioni (ANIK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
1.97%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):